Last reviewed · How we verify

NCT07006662: (LaPBrecon)

Anatomical Landmarks for Chest Wall Perforators Used for Partial Breast Reconstruction

Not yet recruiting Last updated 13 February 2026
What this trial tests

trial in Breast Cancer Female in 20 participants. Not yet recruiting.

Timeline
1 April 2026
Primary endpoint
1 December 2027
1 December 2027

Quick facts

Lead sponsorUniversity Hospitals of North Midlands NHS Trust
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment20
Start date1 April 2026
Primary completion1 December 2027
Estimated completion1 December 2027
Sites1 location across United Kingdom

Conditions studied

Sponsor

University Hospitals of North Midlands NHS Trust

Who can join

18 and older, female only, with Breast Cancer Female. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this 6-month proof-of-concept study is to map out the chest wall perforators in relation to anatomical landmarks for partial breast reconstruction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Breast Cancer Female

Currently open trials in the same condition.

Other University Hospitals of North Midlands NHS Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07006662.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing